liver
Washington (AFP) - The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease. Madrigal Pharmaceuticals' Rezdiffra was shown to improve liver scarring in a clinical trial involving hundreds of people with non-alcoholic steatohepatitis (NASH), the worst form of the condition caused by a buildup of fat in the liver. "Previously, patients with NASH who also have notable liver scarring did not have a medication that could directly address their liver damage," said the FDA's Nikolay Nikolov. "Today's approva...
AFP
This symptom should alarm you even if you don’t feel any discomfort. The liver has few nerve endings, so it can be quite difficult to detect the presence of a malignant tumor in this organ in the early stages. It’s about the color of your stools: if you see that your stools have changed color, in particular, they have become paler or gray for no apparent reason, it is time to go to the doctor. Long-term spaceflight increases brain volumeCoronavirus is beating the US, CDC sets off alarmsWe are all victims of COVID-19: a political virus being spread by WashingtonScientists find a new way to comb...
Revyuh
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら